• Dr. Surolia received her PhD in Biochemistry from the University of Delhi South Campus in 2011. In 2011, she joined UAB’s Division of Pulmonary, Allergy, and Critical Care Medicine as postdoctoral fellow and subsequently Instructor. Dr. Surolia is interested in understanding the molecular pathology of lung injury and repair related to environmental exposures and agents.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury 2019
    2017 Autoimmunity to vimentin is associated with outcomes of patients with idiopathic pulmonary fibrosis 2017
    2017 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs 2017
    2017 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs. 2017
    2017 Low-dose cadmium exposure induces peribronchiolar fibrosis through site-specific phosphorylation of vimentin 2017
    2016 Attenuated heme oxygenase-1 responses predispose the elderly to pulmonary nontuberculous mycobacterial infections 2016
    2015 Heme oxygenase-1 protects Corexit 9500ainduced respiratory epithelial injury across species 2015
    2015 Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated mice 2015
    2014 Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis 2014
    2013 Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury 2013
    2012 Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria 2012
    2012 Preparation and characterization of monensin loaded PLGA nanoparticles: In vitro anti-malarial activity against Plasmodium falciparum 2012
    2011 Inhibition of the growth of plasmodium falciparum in culture by stearylamine-phosphatidylcholine liposomes 2011

    Research Overview

  • Dr. Surolia's ongoing research projects involve toxic environmental exposure leading to COPD and pulmonary fibrosis. Currently, she has also successfully developed and characterized ex-vivo 3D model of lung tissue from patients with IPF. These ex-vivo 3D models are very important in basic research and translational medicine studies such as understanding various biological phenomenon of disease and repair mechanisms. They are an important tool to develop personalized therapies and to develop new drug targets.
  • Full Name

  • Ranu Surolia